[Results of treatment of herpes simplex and herpes zoster with isoprinosine]. 1985

A Polubiec, and K Kołakowska-Polubiec, and K Stepka

UI MeSH Term Description Entries
D007288 Inosine A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)
D007542 Inosine Pranobex An alkylamino-alcohol complex of inosine used in the treatment of a variety of viral infections. Unlike other antiviral agents, it acts by modifying or stimulating cell-mediated immune processes rather than acting on the virus directly. Inosiplex,Methisoprinol,Imunovir,Isoprinosin,Isoprinosine,Methysoprinol,Metisoprinol,NPT-10381,NPT 10381,NPT10381,Pranobex, Inosine
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006561 Herpes Simplex A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.) Herpes Simplex Virus Infection
D006562 Herpes Zoster An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed) Shingles,Zona,Zoster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

A Polubiec, and K Kołakowska-Polubiec, and K Stepka
January 1972, La Prensa medica mexicana,
A Polubiec, and K Kołakowska-Polubiec, and K Stepka
October 1972, Revista. Circulo Argentino de Odontologia,
A Polubiec, and K Kołakowska-Polubiec, and K Stepka
January 1983, Przeglad dermatologiczny,
A Polubiec, and K Kołakowska-Polubiec, and K Stepka
January 1967, The Journal of the College of General Practitioners,
A Polubiec, and K Kołakowska-Polubiec, and K Stepka
October 1988, Srpski arhiv za celokupno lekarstvo,
A Polubiec, and K Kołakowska-Polubiec, and K Stepka
March 1973, British medical journal,
A Polubiec, and K Kołakowska-Polubiec, and K Stepka
March 1973, British medical journal,
A Polubiec, and K Kołakowska-Polubiec, and K Stepka
February 1973, British medical journal,
A Polubiec, and K Kołakowska-Polubiec, and K Stepka
January 1971, Sovetskaia meditsina,
A Polubiec, and K Kołakowska-Polubiec, and K Stepka
January 1996, Irish medical journal,
Copied contents to your clipboard!